Log in
Enquire now
‌

US Patent 9365557 Substituted pyrazin-2-amines as inhibitors of ATR kinase

Patent 9365557 was granted and assigned to Vertex Pharmaceuticals on June, 2016 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Vertex Pharmaceuticals
Vertex Pharmaceuticals
0
Date Filed
March 24, 2014
0
Date of Patent
June 14, 2016
0
Patent Applicant
Vertex Pharmaceuticals
Vertex Pharmaceuticals
0
Patent Application Number
14223109
0
Patent Citations Received
‌
US Patent 11926616 Aminopyrazine diol compounds as PI3K-γ inhibitors
0
Patent Inventor Names
Stephen Young
0
Steven Durrant
0
Alistair Rutherford
0
Anisa Nizarali Virani
0
David Kay
0
Jean-Damien Charrier
0
Joanne Pinder
0
Michael Mortimore
0
Michael O'Donnell
0
Philip Michael Reaper
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9365557
0
Patent Primary Examiner
‌
Douglas M Willis
0

Find more entities like US Patent 9365557 Substituted pyrazin-2-amines as inhibitors of ATR kinase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.